Patents by Inventor Aleksei Aleksandrovich ALEKSANDROV

Aleksei Aleksandrovich ALEKSANDROV has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11993647
    Abstract: The invention relates to medicine. The problem addressed by the present invention consists in creating alternative antibodies or fragments thereof which are capable of specifically binding to a human receptor of interleukin-6 and which would be useful as drugs for treating or diagnosing diseases, or for relieving symptoms, mediated by interleukin-6.
    Type: Grant
    Filed: August 3, 2017
    Date of Patent: May 28, 2024
    Inventors: Stanislav Rudolfovich Evdokimov, Andrei Borisovich Ulitin, Valery Vladimirovich Solovyev, Aleksei Aleksandrovich Aleksandrov, Yulia Sergeevna Chernykh, Timofey Aleksandrovich Nemankin, Anna Konstantinovna Vladimirova, Oleg Igorevich Smotrov, Tatiana Veniaminovna Chernovskaya, Aleksandr Aleksandrovich Moshchenko, Viktoriia Evgenevna Nalobina, Roman Alekseevich Ivanov, Dmitry Valentinovich Morozov
  • Patent number: 11453717
    Abstract: The present invention relates to the field of biotechnology and provides monoclonal tri-specific binding molecules that specifically bind to human IL-17A, human IL-17F, and a human pro-inflammatory molecule (in particular, TNF?) with high affinity. The invention also relates to DNA constructs encoding said binding molecules, related expression vectors and methods of production, and methods of treatment using said binding molecules.
    Type: Grant
    Filed: December 2, 2016
    Date of Patent: September 27, 2022
    Inventors: Dmitry Valentinovich Morozov, Andrei Borisovich Ulitin, Ekaterina Sergeevna Zubareva, Iakov Iurevich Ustiugov, Aleksandr Vladimirovich Karabelskii, Dmitry Valeryevich Korzhavin, Tatiana Veniaminovna Chernovskaya, Aleksandr Valerevich Grachev, Yury Ivanovich Basovskiy, Ekaterina Aleksandrovna Lomkova, Veronika Sergeevna Usatova, Aleksei Aleksandrovich Aleksandrov, Elena Leonidovna Morozova, Roman Alekseevich Ivanov, Pavel Andreevich Iakovlev
  • Publication number: 20220089761
    Abstract: The present invention relates to biotechnology and provides a monoclonal antibody that specifically binds to CD20. The invention also relates to DNA encoding said antibody, the corresponding expression vectors and methods of production thereof, as well as methods of treatment using said antibody.
    Type: Application
    Filed: October 30, 2019
    Publication date: March 24, 2022
    Inventors: Pavel Andreevich IAKOVLEV, Natalia Eugenievna PESTOVA, Arina Vitalevna ANIKINA, Anna Alexandrovna TRUDOVISHNIKOVA, Mariia Aleksandrovna SHCHEMELEVA, Nina Grachyaevna KHARATIAN, Valery Vladimirovich SOLOVYEV, Alexey Konstantinovich MISORIN, Sergei Vasilyevich DIDUK, Anna Vladimirovna EROSHOVA, Veronika Sergeevna USATOVA, Elena Andreevna KRENDELEVA, Iakov Iurevich USTIUGOV, Aleksei Aleksandrovich ALEKSANDROV, Iana Andreevna SMIRNOVA, Svetlana Vladimirovna KOSKOVA, Roman Alekseevich IVANOV, Dmitry Valentinovich MOROZOV
  • Patent number: 11236167
    Abstract: The present invention relates to the field of biotechnology and provides antibodies that specifically binds to PD-L1. The invention also relates to DNA encoding said antibodies, to corresponding expression vectors and to methods of producing, and to methods of treatment using said antibodies.
    Type: Grant
    Filed: April 11, 2018
    Date of Patent: February 1, 2022
    Inventors: Andrei Borisovich Ulitin, Viktoriia Mikhailovna Ekimova, Ekaterina Vladimirovna Sofronova, Yulia Sergeevna Chernykh, Sergei Andreevich Ageev, Anna Konstantinovna Vladimirova, Aleksei Aleksandrovich Aleksandrov, Pavel Alekseevich Grebnev, Valery Vladimirovich Solovyev, Iakov Iurevich Ustiugov, Pavel Andreevich Iakovlev, Timofey Aleksandrovich Nemankin, Dmitry Valentinovich Morozov
  • Publication number: 20210332120
    Abstract: The present invention relates to the field of biotechnology and provides monoclonal tri-specific binding molecules that specifically bind to human IL-17A, human IL-17F, and a human pro-inflammatory molecule (in particular, TNF?) with high affinity. The invention also relates to DNA constructs encoding said binding molecules, related expression vectors and methods of production, and methods of treatment using said binding molecules.
    Type: Application
    Filed: December 2, 2016
    Publication date: October 28, 2021
    Inventors: Dmitry Valentinovich MOROZOV, Andrei Borisovich ULITIN, Ekaterina Sergeevna ZUBAREVA, Iakov Iurevich USTIUGOV, Aleksandr Vladimirovich KARABELSKII, Dmitry Valeryevich KORZHAVIN, Tatiana Veniaminovna CHERNOVSKAYA, Aleksandr Valerevich GRACHEV, Yury Ivanovich BASOVSKIY, Ekaterina Aleksandrovna LOMKOVA, Veronika Sergeevna USATOVA, Aleksei Aleksandrovich ALEKSANDROV, Elena Leonidovna MOROZOVA, Roman Alekseevich IVANOV, Pavel Andreevich IAKOVLEV
  • Publication number: 20200369771
    Abstract: The present invention relates to the field of biotechnology and provides antibodies that specifically binds to PD-L1. The invention also relates to DNA encoding said antibodies, to corresponding expression vectors and to methods of producing, and to methods of treatment using said antibodies.
    Type: Application
    Filed: April 11, 2018
    Publication date: November 26, 2020
    Inventors: Andrey Borisovich ULITIN, Victoria Mikhailovna EKIMOVA, Ekaterina Vladimirovna SOFRONOVA,, Yulia Sergeevna CHERNYKH, Sergei Andreevich AGEEV, Anna Konstantinovna VLADIMIROVA, Aleksei Aleksandrovich ALEKSANDROV, Pavel Alekseevich GREBNEV, Valery Vladimirovich SOLOVYEV, Iakov Iurevich USTIUGOV, Pavel Andreevich IAKOVLEV, Timofey Aleksandrovich NEMANKIN, Dmitry Valentinovich MOROZOV
  • Publication number: 20190194313
    Abstract: The invention relates to medicine. The problem addressed by the present invention consists in creating alternative antibodies or fragments thereof which are capable of specifically binding to a human receptor of interleukin-6 and which would be useful as drugs for treating or diagnosing diseases, or for relieving symptoms, mediated by interleukin-6.
    Type: Application
    Filed: August 3, 2017
    Publication date: June 27, 2019
    Inventors: Stanislav Rudolfovich EVDOKIMOV, Andrei Borisovich ULITIN, Valery Vladimirovich SOLOVYEV, Aleksei Aleksandrovich ALEKSANDROV, Yulia Sergeevna CHERNYKH, Timofey Aleksandrovich NEMANKIN, Anna Konstantinovna VLADIMIROVA, Oleg Igorevich SMOTROV, Tatiana Veniaminovna CHERNOVSKAYA, Aleksandr Aleksandrovich MOSHCHENKO, Viktoriia Evgenevna NALOBINA, Roman Alekseevich IVANOV, Dmitry Valentinovich MOROZOV